A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis.

Journal Article (Clinical Trial;Journal Article)

Venous thromboembolism is a serious complication following gynecologic surgery and is particularly common in patients with malignancy. A previous study of subcutaneous low-dose heparin given as one dose preoperatively and every 12 hours postoperatively failed to show a benefit in gynecologic oncology patients. In the present study, two more intense regimens of low-dose heparin were evaluated. Three hundred four patients were assigned randomly to receive no prophylaxis (controls), subcutaneous heparin 5000 units 2 hours before surgery and every 8 hours postoperatively (low-dose heparin) (regimen I), or 5000 units heparin subcutaneously every 8 hours preoperatively (between two and nine doses) and every 8 hours postoperatively (regimen II). All patients had thromboembolism surveillance with the fibrinogen uptake test and clinical evaluation. Eighty-four percent had a malignancy. Thromboemboli were diagnosed in 19 of 103 control patients, ten of 104 regimen I patients, and six of 97 regimen II patients, a statistically significant difference (P less than .008). When compared with the control group, the study groups had no evidence of increased bleeding complications or alteration of laboratory coagulation indicators.

Full Text

Duke Authors

Cited Authors

  • Clark-Pearson, DL; DeLong, E; Synan, IS; Soper, JT; Creasman, WT; Coleman, RE

Published Date

  • April 1990

Published In

Volume / Issue

  • 75 / 4

Start / End Page

  • 684 - 689

PubMed ID

  • 2179782

International Standard Serial Number (ISSN)

  • 0029-7844


  • eng

Conference Location

  • United States